Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-196-5 | CAS number: 92-84-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010-03-17 to 2010-04-30
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Well performed GLP study according to recent OECD guidelines.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Certificate attached to full study report.
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Phenothiazine
- EC Number:
- 202-196-5
- EC Name:
- Phenothiazine
- Cas Number:
- 92-84-2
- Molecular formula:
- C12H9NS
- IUPAC Name:
- 10H-phenothiazine
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, 97633 Sulzfeld, Germany
- Age at study initiation: females: 18-19 weeks; males: 8-9 weeks
- Weight at study initiation: femailes: 215-228g; males: 240-260g
- Housing: Full barrier in an air-conditioned room, animals were kept individually in IVC cages, type III H, polysulphone cages on Altomin saw fibre bedding
- Diet (e.g. ad libitum): Altromin 1324, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Certificates of food, water and bedding are filed at the test facility
- Acclimation period: at least five days
- Female rats were nulliparous and non-pregnant
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C +/- 3°C
- Humidity (%): 55% +/- 10%
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12hrs / 12hrs
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- other: Corn oil (Sigma-Aldrich)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: dorsal area of the trunk (approx. 24hrs before the test, the fur was removed by using an electrical clipper)
- % coverage: 10%
- Type of wrap if used: semi-occlusive dressing consisted of a gauze-dressing and non-irritating tape and was fixed with an additional dressing in a suitable manner.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): at the end of exposure period residual test item was removed by using corn oil
- Time after start of exposure: 24hrs
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): at a single dose of 2000 mg/kg body weight
- Constant volume or concentration used: yes
- For solids, paste formed: yes, moistened with vehicle
- The test item was ground to a fine powder in a mortar with the help of a pestle
- In order to ensure good skin contact it was moistened with the vehicle
VEHICLE
- Lot/batch no. (if required): lot no. 128K0040, expiry date: 25/04/2010
- Rationale: This vehicle was chosen due to its non-irritating characteristics - Duration of exposure:
- 24hrs
- Doses:
- 2000mg/kg body weight
- No. of animals per sex per dose:
- 5 females and 5 males
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: weighing on day 1 (prior to application) and on days 8 and 15, clinical examination was made several times on day of dosing (at least once during the first 30mins and with special attention given during the first 4hrs post-dose).
- Necropsy of survivors performed: yes, all gross pathological changes were recorded.
- Other examinations performed: clinical signs, body weight
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: The test item showed no sign of acute dermal toxicity.
- Mortality:
- No mortalities.
- Clinical signs:
- other: No findings during the entire observation period.
- Gross pathology:
- No specific gross pathological changes were recorded for any animal, with the exception of acute injection of blood vessels in the abdominal region, which is due to the euthanasia injection.
- Other findings:
- Signs of irritation
- Erythema grade 1 was observed in 4/5 female and 5/5 male animals
- Erythema grade 2 was observed in 3/5 male animals
- Desquamation and eschar were observed in 5/5 female and 5/5 male animals
- Scratches were observed in 3/5 female and 5/5 male animals
- Not all signs of irritation were reversible with the observation period
Any other information on results incl. tables
TABLE: Skin Irritation – Individual Data – Females
Day after |
Animal No. 11 |
Animal No. 12 |
Animal No. 13 |
Animal No. 14 |
Animal No. 15 |
|||||
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
|
day 2 |
1/0 |
nf |
1/0 |
nf |
0/0 |
nf |
0/0 |
* |
0/0 |
* |
day 3 |
1/0 |
nf |
1/0 |
nf |
0/0 |
nf |
0/0 |
* |
0/0 |
* |
day 4 |
1/0 |
slight s |
1/0 |
nf |
0/0 |
nf |
0/0 |
* |
0/0 |
* |
day 5 |
0/0 |
s, d |
1/0 |
d |
1/0 |
d |
0/0 |
slight d |
0/0 |
d |
day 6 |
0/0 |
d, es |
1/0 |
d |
1/0 |
d, es |
0/0 |
slight d |
1/0 |
d, es |
day 7 |
0/0 |
d, es |
0/0 |
d, es |
0/0 |
d, es |
0/0 |
d, slight s |
0/0 |
d, s |
day 8 |
0/0 |
d, es |
0/0 |
d, es |
0/0 |
d, es |
0/0 |
d |
0/0 |
slight d |
day 9 |
0/0 |
slight d, |
0/0 |
d, es |
0/0 |
d, es |
0/0 |
d |
0/0 |
slight d |
day 10 |
0/0 |
nf |
0/0 |
d, es |
0/0 |
d, es |
0/0 |
moderate d |
0/0 |
slight d |
day 11 |
0/0 |
slight d, |
0/0 |
moderate d |
0/0 |
slight d |
0/0 |
slight d |
0/0 |
nf |
day 12 |
0/0 |
slight d |
0/0 |
slight d |
0/0 |
nf |
0/0 |
nf |
0/0 |
nf |
day 13 |
0/0 |
slight d |
0/0 |
slight d |
0/0 |
nf |
0/0 |
nf |
0/0 |
nf |
day 14 |
0/0 |
slight d |
0/0 |
nf |
0/0 |
nf |
0/0 |
nf |
0/0 |
nf |
day 15 |
0/0 |
nf |
0/0 |
nf |
0/0 |
nf |
0/0 |
nf |
0/0 |
nf |
Comments: E = erythema; O = oedema; 1, 2, 3, 4 = scoring system laid down in OECD Guideline 404 (Table 2) d = desquamation; es = eschar; s = scratches; nf = no findings * orange discoloration at the application site, caused by the test item |
TABLE: Skin irritation – Individual Data – Males
Day after |
Animal No. 21 |
Animal No. 22 |
Animal No. 23 |
Animal No. 24 |
Animal No. 25 |
|||||
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
|
day 2 |
0/0 |
* |
0/0 |
* |
0/0 |
* |
0/0 |
* |
0/0 |
* |
day 3 |
0/0 |
* |
0/0 |
* |
0/0 |
* |
0/0 |
* |
0/0 |
* |
day 4 |
0/0 |
* |
0/0 |
* |
0/0 |
* |
0/0 |
* |
0/0 |
* |
day 5 |
2/0 |
d, es |
1/0 |
d, es |
1/0 |
d, es |
2/0 |
d, es |
2/0 |
d, es |
day 6 |
1/0 |
d, es |
1/0 |
d, es |
0/0 |
d, es |
1/0 |
d, es |
1/0 |
d, es |
day 7 |
0/0 |
d, es |
0/0 |
d, es |
0/0 |
d, es, ** |
0/0 |
d, es, ** |
0/0 |
d, es,* |
day 8 |
0/0 |
slight d, es |
0/0 |
slight d, es |
0/0 |
slight d, es, |
0/0 |
slight d, es, |
0/0 |
slight d, es, |
day 9 |
0/0 |
slight d, es |
0/0 |
slight d, es, |
0/0 |
slight d, es, |
0/0 |
slight d, es, |
0/0 |
slight d, es, |
day 10 |
0/0 |
slight d, es |
0/0 |
slight d, es, |
0/0 |
slight d, es, |
0/0 |
slight d, es, |
0/0 |
slight d, es, |
day 11 |
0/0 |
moderate d, |
0/0 |
slight d |
0/0 |
slight d, es, |
0/0 |
slight d, es, s, |
0/0 |
slight d, es, |
day 12 |
0/0 |
slight d, es, |
0/0 |
slight d |
0/0 |
slight d, es, |
0/0 |
slight es, s, |
0/0 |
d, es, **, s |
day 13 |
0/0 |
slight d, es, |
0/0 |
slight d |
0/0 |
slight d, es, |
0/0 |
slight es, s, |
0/0 |
d, es |
day 14 |
0/0 |
es |
0/0 |
slight d |
0/0 |
es |
0/0 |
es |
0/0 |
d, es |
day 15 |
0/0 |
es |
0/0 |
nf |
0/0 |
es |
0/0 |
es |
0/0 |
nf |
Comments: E = erythema; O = oedema; 1, 2, 3, 4 = scoring system laid down in OECD Guideline 404 (Table 2) d = desquamation; es = eschar; s = scratches; s#: punctiform scratches, nf = no findings * orange discoloration at the application site, caused by the test item ** small wound |
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the present study, single dermal application of phenothiazine to rats at a dose of 2000mg/kg body weight was associated with no signs of toxicity or mortality, but with signs of irritation. The dermal LD50 was determined to be greater than 2000mg/kg body weight. Phenothiazine does not require classification for acute percutaneous toxicity according to the provisions laid down in Regulation (EC) No 1272/2008.
- Executive summary:
- Phenothiazine was tested for acute dermal Toxicity according to OECD guideline 402 and according to Regulation (EC) No 440/2008, Method B.3.
- Study was conducted as limit test (2000mg/kg body weight)
- 5 male and 5 female Wistar rats (Crl: WI(HAN)) were used in this study
- Corn oil was used as vehicle
- Rats were dermal exposed to phenothiazine for 24hrs
- Signs of toxicity related to dose level used, time of onset and duration were not observed (no treatment-related effects)
- No effects on organs (related to dose level) were observed
- LD50 is greater than 2000mg/kg body weight
- Signs of irritation were found in some animals. Not all signs were reversible within the observation period.
- Phenothiazine does not require classification for acute percutaneous toxicity according to the provisions laid down in Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.